Ingenii offers a data analytics and engineering platform that provides quantum algorithms specific to life sciences, environmental research, pharmaceuticals, and healthcare without requiring in-house quantum development. The platform integrates with leading quantum software and service providers to embed quantum capabilities into a conventional technology stack via a simplified interface. Ingenii is focused on commercializing its product and accelerating its quantum R&D to address engineering challenges ahead of peak market adoption. The company targets a broad set of industry sectors (manufacturing, chemicals, biotechnology, agriculture, and pharmaceuticals) and cites a total market opportunity of over $45B. Operationally, Ingenii reports it has successfully renewed 100% of its 2021 contracts that came up for renewal, which the company says validates its platform's value. The company is based in New York, NY and has launched a crowdfunding campaign to support further product-market fit work.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2022